ABBV-8736

DRUG3 trials

Sponsors

AbbVie

Conditions

Crohn's DiseaseHealthy Volunteer

Phase 1

A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy Volunteers

Active, not recruitingNCT07141199

AbbVieHealthy Volunteer

Start: 2025-09-02End: 2026-04-01Updated: 2026-02-23

A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers

RecruitingNCT07413133

AbbVieHealthy Volunteer

Start: 2026-02-11End: 2026-06-01Target: 40Updated: 2026-03-04

Phase 2

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RecruitingNCT06548542

AbbVieCrohn's Disease

Start: 2024-09-04End: 2028-08-01Target: 540Updated: 2026-04-01